HealthEquity HQY 深 沪
已收盘 10-16 16:00:00 美东时间
92.03
-0.480
-0.52%
华盛通- 最 高93.835
- 今 开93.23
- 成交量 55.07万股
- 最 低 91.625
- 昨 收 92.51
- 总市值 76.12亿
- 52周最高 107.62
- 市盈率 静 37.41
- 换手率 0.67%
- 52周最低 72.76
- 委 比 -12.61%
- 总股本 8271.53万
- 历史最高 116.65
- 量 比 0.77
- 振 幅 2.39%
- 历史最低 15.80
- 每 手 1
- 风险率 8.20%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HealthEquity收跌0.52%，成交额5078.81万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
今天 04:59
HealthEquity Announces Chief Commercial Officer Leadership Change
Healthequity ( ($HQY) ) has provided an announcement. HealthEquity, Inc. termin...
10-10 05:32
UBS flags 56 stocks where growth and profitability may be underpriced
UBS Global Research has constructed a 56-stock basket of U.S. companies with higher forward growth, stronger cash-flow profitability and improving earnings momentum, arguing that valuations for some o...
10-08 18:29
HealthEquity adds Moody’s CFO Heuland to board
Healthequity ( ($HQY) ) just unveiled an update. On September 24, 2026, HealthE...
09-30 21:29
HealthEquity Appoints Moody’s CFO Noémie Heuland to Board of Directors
HealthEquity, the largest independent health savings account (HSA) custodian, announced that Noémie Heuland, Chief Financial Officer of Moody’s Corporation, has been elected to its board of directors effective Sept. 24, 2026. Heuland will also serve on the Audit and Risk Committee and Cybersecurity and Technology Committee, expanding the Board to 11 directors, nine of whom are independent. Robert Selander, Chairman of the Board, highlighted Heula...
09-30 13:00
美股大行评级 | 奈飞遭看淡至57美元！现价仍有两成下行空间；Xenon制药遭多家机构降目标价，最低看至46美元
今日重点评级关注：康托·菲茨杰拉德：维持Abeona Therapeutics"超配"评级，目标价从28美元升至30美元；HC Wainwright & Co.：维持Oculis Holding"买入"评级，目标价从26美元升至39美元
09-21 16:25
Barclays Maintains Overweight on HealthEquity, Raises Price Target to $115
Barclays analyst Peter Warendorf maintains HealthEquity (NASDAQ:HQY) with a Overweight and raises the price target from $110 to $115.
09-18 21:07
美股大行评级 | Affirm、GitLab获多家大行上调目标价；Attovia获大摩、花旗首予买入评级
今日重点评级关注：杰富瑞：维持拜玛林制药"买入"评级，目标价从104美元升至105美元；RBC Capital：维持Shift4 Payments"跑赢大市"评级，目标价从63美元升至67美元
09-01 08:37
美股大行评级 | 潜在涨幅768.26%！Ascendiant Capital维持RenovoRx(RNXT)"买入"评级，目标价上调至14.5美元
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从14美元升至14.5美元；HC Wainwright & Co.：维持Generate Biomedicines"买入"评级，目标价从25美元升至30美元
08-31 18:14
BTIG Reiterates Buy on HealthEquity, Maintains $115 Price Target
BTIG analyst David Larsen reiterates HealthEquity (NASDAQ:HQY) with a Buy and maintains $115 price target.
08-28 18:34
